750347
Last Update Posted: 2011-01-19
Recruiting has ended
All Genders accepted | 18 Years-40 Years |
24 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Antagonistic Interaction CB1-paracetamol
Evaluation of an possible inhibiting effect of Rimonabant on the analgesic effect of Paracetamol in healthy volunteers
Double Blind, cross-over, randomized and controlled versus placebo, study in healthy volunteers.
Eligibility
Relevant conditions:
Pain
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov